{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:35:29Z","timestamp":1794339329122,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.mayocp.2022.11.001","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T10:00:25Z","timestamp":1677664825000},"page":"458-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Approach to Disorders of Gut-Brain Interaction"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-1695","authenticated-orcid":false,"given":"June","family":"Tome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8296-1029","authenticated-orcid":false,"given":"Amrit K.","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor G.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2022.11.001_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ajg.2017.421","article-title":"The prevalence and impact of overlapping Rome IV-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: a cross-sectional general population study in three countries","volume":"113","author":"Aziz","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.mayocp.2022.11.001_bib2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.cgh.2020.06.065","article-title":"Prevalence and characteristics of abdominal pain in the United States","volume":"19","author":"Lakhoo","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.11.001_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mayocp.2022.11.001_bib4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1053\/j.gastro.2016.02.027","article-title":"Biopsychosocial aspects of functional gastrointestinal disorders","volume":"150","author":"Van Oudenhove","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mayocp.2022.11.001_bib5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.amjmed.2019.09.027","article-title":"The enduring and practical power of physical examination: Carnett Sign","volume":"133","author":"Schneiderman","year":"2020","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2022.11.001_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mayocp.2018.09.018","article-title":"Chronic abdominal wall pain: a common yet overlooked etiology of chronic abdominal pain","volume":"94","author":"Kamboj","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.mayocp.2022.11.001_bib7","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.cgh.2020.06.043","article-title":"Effects of Rome IV definitions of functional dyspepsia subgroups in secondary care","volume":"19","author":"Van den Houte","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.11.001_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S2468-1253(18)30003-7","article-title":"Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study","volume":"3","author":"Aziz","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.11.001_bib9","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-functional GI disorders: disorders of gut-brain interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.mayocp.2022.11.001_bib10","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/j.1572-0241.2007.01254.x","article-title":"What patients know about irritable bowel syndrome (IBS) and what they would like to know. National survey on patient educational needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ)","volume":"102","author":"Halpert","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.11.001_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gutjnl-2016-312361","article-title":"Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts","volume":"67","author":"Simr\u00e9n","year":"2018","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.mayocp.2022.11.001_bib12","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/gutjnl-2011-300474","article-title":"The brain-gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study","volume":"61","author":"Koloski","year":"2012","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.mayocp.2022.11.001_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/apt.15325","article-title":"Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome","volume":"50","author":"Zamani","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mayocp.2022.11.001_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12955-018-0913-z","article-title":"Factors associated with health-related quality of life in patients with functional dyspepsia","volume":"16","author":"Hantoro","year":"2018","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10.1016\/j.mayocp.2022.11.001_bib15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1572-0241.2000.01941.x","article-title":"Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire","volume":"95","author":"Drossman","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.11.001_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/2050640619900577","article-title":"Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: a population study","volume":"8","author":"Lj\u00f3tsson","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.mayocp.2022.11.001_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/1477-7525-11-208","article-title":"Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients","volume":"11","author":"Andrae","year":"2013","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.mayocp.2022.11.001_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/apt.16072","article-title":"Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia","volume":"53","author":"Ford","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mayocp.2022.11.001_bib19","article-title":"Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome","volume":"8","author":"Ruepert","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mayocp.2022.11.001_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2468-1253(19)30324-3","article-title":"Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis","volume":"5","author":"Black","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.mayocp.2022.11.001_bib21","doi-asserted-by":"crossref","first-page":"a2313","DOI":"10.1136\/bmj.a2313","article-title":"Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis","volume":"337","author":"Ford","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.mayocp.2022.11.001_bib22","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000021","article-title":"A\u00a0novel, duodenal-release formulation of a combination of caraway oil and L-menthol for the treatment of functional dyspepsia: a randomized controlled trial","volume":"10","author":"Chey","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.11.001_bib23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/MCG.0b013e3182a88357","article-title":"Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis","volume":"48","author":"Khanna","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.mayocp.2022.11.001_bib24","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.cgh.2021.11.035","article-title":"Impact of bile acid diarrhea in patients with diarrhea-predominant irritable bowel syndrome on symptoms and quality of life","volume":"20","author":"BouSaba","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.11.001_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.mayocp.2016.01.015","article-title":"Lubiprostone is effective in the treatment of chronic idiopathic constipation and irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"91","author":"Li","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.mayocp.2022.11.001_bib26","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cgh.2013.04.032","article-title":"Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis","volume":"11","author":"Videlock","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.11.001_bib27","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cgh.2013.09.022","article-title":"Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipation","volume":"12","author":"Rao","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.11.001_bib28","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/j.pain.0000000000002181","article-title":"Ultrasound-guided transversus abdominis plane block versus trigger point injections for chronic abdominal wall pain: a randomized clinical trial","volume":"162","author":"Moeschler","year":"2021","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.mayocp.2022.11.001_bib29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MCG.0000000000001164","article-title":"Practical perspectives in the treatment of nausea and vomiting","volume":"53","author":"Cangemi","year":"2019","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.11.001_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.mayocp.2021.10.030","article-title":"A\u00a0practical 5-step approach to nausea and vomiting","volume":"97","author":"Tome","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.mayocp.2022.11.001_bib31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.gastro.2015.10.047","article-title":"Ramosetron reduces symptoms of irritable bowel syndrome with diarrhea and improves quality of life in women","volume":"150","author":"Fukudo","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.mayocp.2022.11.001_bib32","first-page":"535","article-title":"Comparative effectiveness of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: a network meta-analysis of randomized controlled studies","volume":"34","author":"Rokkas","year":"2021","journal-title":"Ann Gastroenterol"},{"issue":"7","key":"10.1016\/j.mayocp.2022.11.001_bib33","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG clinical guideline: management of dyspepsia","volume":"112","author":"Moayyedi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mayocp.2022.11.001_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-230X-12-42","article-title":"Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS)","volume":"12","author":"Sakurai","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.11.001_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ajg.2017.458","article-title":"Effects of antidepressants on gastric function in patients with functional dyspepsia","volume":"113","author":"Lacy","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.11.001_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41395-018-0222-5","article-title":"Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis","volume":"114","author":"Ford","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.11.001_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13030-021-00205-2","article-title":"A\u00a0randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome","volume":"15","author":"Khalilian","year":"2021","journal-title":"Biopsychosoc Med"},{"issue":"5","key":"10.1016\/j.mayocp.2022.11.001_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MCG.0000000000001034","article-title":"Gabapentin improves symptoms of functional dyspepsia in a retrospective, open-label cohort study","volume":"53","author":"Staller","year":"2019","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.11.001_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.dld.2013.09.002","article-title":"Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome","volume":"46","author":"Iturrino","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"8","key":"10.1016\/j.mayocp.2022.11.001_bib40","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/apt.16588","article-title":"Randomised clinical trial: the effects of pregabalin versus placebo on functional dyspepsia","volume":"54","author":"Kotikula","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.mayocp.2022.11.001_bib41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ajg.2013.105","article-title":"Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life","volume":"108","author":"Bohn","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.mayocp.2022.11.001_bib42","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2013.01.049","article-title":"A\u00a0controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function","volume":"144","author":"Vazquez-Roque","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mayocp.2022.11.001_bib43","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00394-015-0922-1","article-title":"Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis","volume":"55","author":"Marsh","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.mayocp.2022.11.001_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpsychores.2018.02.015","article-title":"Transdiagnostic internet-delivered cognitive-behaviour therapy (CBT) for adults with functional gastrointestinal disorders (FGID): a feasibility open trial","volume":"108","author":"Dear","year":"2018","journal-title":"J\u00a0Psychosom Res"},{"issue":"1","key":"10.1016\/j.mayocp.2022.11.001_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.gastro.2018.03.063","article-title":"Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory irritable bowel syndrome","volume":"155","author":"Lackner","year":"2018","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.mayocp.2022.11.001_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13573","article-title":"Gut-focused hypnotherapy for functional gastrointestinal disorders: evidence-base, practical aspects, and the Manchester Protocol","volume":"31","author":"Vasant","year":"2019","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"10.1016\/j.mayocp.2022.11.001_bib47","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamapediatrics.2017.0091","article-title":"Home-based hypnotherapy self-exercises vs. individual hypnotherapy with a therapist for treatment of pediatric irritable bowel syndrome, functional abdominal pain, or functional abdominal pain syndrome: a randomized clinical trial","volume":"171","author":"Rutten","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"3","key":"10.1016\/j.mayocp.2022.11.001_bib48","doi-asserted-by":"crossref","first-page":"350","DOI":"10.14309\/ajg.0000000000000539","article-title":"Complementary and alternative medicine for functional gastrointestinal disorders","volume":"115","author":"Deutsch","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.mayocp.2022.11.001_bib49","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622006188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622006188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T01:33:03Z","timestamp":1701999183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622006188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0025619622006188"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.11.001","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to Disorders of Gut-Brain Interaction","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}